Final
BILL SUMMARY for HB05-1209

HOUSE COMMITTEE ON FINANCE

Votes:
Action Taken:
Moved amendment L.006 (Attachment P). (The amendm
Moved amendment L.007. (The amendment makes a tec
Refer HB 05-1209, as amended, to the Committee on 		TIE
Pass Without Objection
PASS


04:48 PM -- House Bill 05-1209 - Concerning Compounding Drugs

Representative McFayden, prime sponsor, distributed amendment L.007 (Attachment N) and explained that House Bill 05-1209 specifies that compounding drugs are included in the practice of pharmacy. The bill removes the sale of compounded drugs from the requirements of the "casual sale" of prescription drugs and removes the requirement that compounded drugs be the result of a practitioner's prescription drug order for the purpose of research, teaching, or chemical analysis.

04:57 PM -- Dr. Melanie Marsden, representing herself, distributed a handout on the random testing of compounding drugs (Attachment O) and testified in opposition to the bill. Dr. Marsden continued by explaining the definition of compounding drugs. She closed by commenting on some quality control issues that could arise should the bill be enacted into law.

05:18 PM -- Ms. Susan Warren, State Board of Pharmacies, Department of Regulatory Agencies (DORA), testified in opposition to the bill and commented that DORA's primary concern is for the safety of Colorado citizens. She commented that the current system allows for drug compounding and discussed regulatory applications that apply to pharmacies. She closed by saying that the bill takes away the requirement that pharmacists compound according to a physicians' orders.

05:39 PM -- Mr. Tom Bader, Compounding Only R/X in Colorado Springs, testified in support of the legislation.

05:53 PM -- Mr. Joe Wise, Wise R/X Compounding, testified in support of the legislation.

05:55 PM -- Mr. Chris Howes, International Academy of Compounding Pharmacists (IACP) of Colorado, testified in support of the legislation.

06:04 PM -- Mr. Jerry Eubanks, Compounding Pharmacists, testified in support of the legislation. He commented that House Bill 05-1209 is about good patient care.

06:13 PM -- Mr. Mark Kinney, R/X Plus Pharmacies, testified in support of the legislation.

06:16 PM -- Ms. Susan Cox, Kaiser Permanente, testified in support of the legislation. She stated that the legislation would centralize the in-house use of compounding drugs for Kaiser and make prescription drugs cheaper for Kaiser members.
BILL:HB05-1209
TIME: 06:19:08 PM
MOVED:Frangas
MOTION:Moved amendment L.007. (The amendment makes a technical clarification.) The motion passed without objection by those members present.
SECONDED:Marshall
VOTE
Benefield
Cloer
Excused
Crane
Frangas
Garcia
Jahn
Marshall
Massey
May M.
McCluskey
Witwer
Judd
Vigil
Not Final YES: 0 NO: 0 EXC: 1 ABS: 0 FINAL ACTION: Pass Without Objection
BILL:HB05-1209
TIME: 06:29:25 PM
MOVED:Witwer
MOTION:Moved amendment L.006 (Attachment P). (The amendment would have prohibited casual sales.) The motion died for a lack of a second.
SECONDED:
VOTE
Benefield
Cloer
Excused
Crane
Frangas
Garcia
Jahn
Marshall
Massey
May M.
McCluskey
Witwer
Judd
Vigil
Not Final YES: 0 NO: 0 EXC: 1 ABS: 0 FINAL ACTION: TIE
BILL:HB05-1209
TIME: 06:29:48 PM
MOVED:Judd
MOTION:Refer HB 05-1209, as amended, to the Committee on Appropriations. The motion passed on a 11-1-1 vote.
SECONDED:Frangas
VOTE
Benefield
Yes
Cloer
Excused
Crane
Yes
Frangas
Yes
Garcia
Yes
Jahn
Yes
Marshall
Yes
Massey
Yes
May M.
Yes
McCluskey
Yes
Witwer
No
Judd
Yes
Vigil
Yes
Final YES: 11 NO: 1 EXC: 1 ABS: 0 FINAL ACTION: PASS